The latest price of ruxolitinib tablets/ruxolitinib in 2025

Ruxolitinib tablets/Ruxolitinib (Ruxolitinib) is an oral small molecule JAK1/JAK2 inhibitor, mainly used for the treatment of myelofibrosis, polycythemia vera and graft-versus-host disease (GvHD) and other related blood diseases. The drug improves disease-related symptoms by selectively inhibiting the JAK signaling pathway, blocking abnormal cytokine signaling, and regulating blood cell production and inflammatory responses. Due to its precise mechanism of action and efficacy, ruxolitinib has been widely used in hematology clinics.

In the domestic market, the original drug ruxolitinib is launched in the form of ruxolitinib phosphate tablets and is included in the reimbursement scope of Class B medical insurance. Qualified patients can obtain part of the cost reimbursement through medical insurance. Common specifications include20mg 14 tablets and 5mg 60 tablets, with the price of each box being about 3,000 yuan. Although the price is higher, medical insurance coverage significantly eases the financial burden on patients during long-term treatment. The purchase and use of drugs must be carried out under the guidance of professional doctors to ensure the safety and stable efficacy of the drugs.

There are certain differences in the prices of ruxolitinib original drug in overseas markets. For example, the Turkish version of ruxolitinib has a specification of 5 mg and 60 tablets per box, and the price may be around 4,000 yuan. However, due to exchange rate fluctuations and market policies, the price may be adjusted at any time. In addition, there are also generic drugs on the overseas market, such as 5mg and 50 tablets produced by a Bangladeshi pharmaceutical factory, with a price of more than 1,000 yuan per box. Although the price is lower, the ingredients are basically the same as the original drug, providing a feasible treatment option for patients with limited financial conditions.

The price difference requires patients to consider factors such as drug sources, affordability, and medical insurance policies when choosing treatment options. Domestic original drugs can be obtained through medical insurance reimbursement and regular hospitals, which can ensure drug quality and medication management practices. Although overseas generic drugs provide economic alternatives, production qualifications and legality still need to be paid attention to.

Reference materials:https://www.jakavi.com/